Chairman of the Board
Mr. Hurvitz established CH-health, a private venture capital firm, and is serving as its CEO since May 2011. He is the chairman of Galmed Pharmaceuticals board of directors since 2011, board member in UroGen Pharma ltd. and a member of the presidency board of the Manufacturers Association of Israel, chairing its pharmaceutical branch. Mr. Hurvitz was a member of the board of directors in Teva from 2010 to July 2014 and held various top positions therein since 1992, including president of Teva International Group, president and CEO of Teva Pharmaceuticals Europe as well as VP of Israeli Pharmaceutical Sales. Mr. Hurvitz holds a Bachelor of Arts degree in Political Science and Economics from Tel Aviv University awarded in 1985.